XRAY - dentsplysirona.com Enterprise Value

Brandmark of Sirona Dental Systems (XRAY)

This daily price chart for DENTSPLY SIRONA Inc. (XRAY) reflects a business valuation of 3972.84. High returns are driven by the sale of 3D design software and ancillary materials, which reduces capital expenditures. Stability is supported by a broad portfolio of dental products and digital services for global clinics, while the updated management team is successfully optimizing internal processes to restore investor confidence.

Dentsply (XRAY) Total Company Value: for the period 11/23/2025 - 10/31/2026

DENTSPLY SIRONA Inc. (XRAY) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price Performance Chart Dentsply Sirona Inc|XRAY - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Dentsply Sirona|XRAY - Real Price to Acquire Entire Company
- book value of equity indicators:
Net Asset Value per Share Dentsply Sirona|XRAY - Company Book Value|Market Cap to Net Assets Ratio dentsplysirona.com|XRAY - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital DENTSPLY SIRONA Inc.|XRAY - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio dentsplysirona.com|XRAY - Company Aggregate Debts|Debts to Net Assets Dentsply Sirona|XRAY - Company Long-Term Debts|Company Current Liabilities Dentsply Sirona|Quick Ratio dentsplysirona.com
- earnings and market multiples details:
XRAY - Company Net Income
Summary company analytics:XRAY Dentsply Sirona Inc
Manufactured product of Dentsply Sirona Inc

Enterprise Value (EV) serves as an integral metric for the total acquisition cost of a business, combining market capitalization with net debt to eliminate distortions caused by financing structures. Analyzing the historical enterprise value chart of DENTSPLY SIRONA Inc. (XRAY), an investor can see how mature leadership in the dental sector and production optimization ensure the stability of this valuation relative to operating income.

Who DENTSPLY SIRONA Inc. competes with

Value Adjusted for Debt and Cash ISRG|Danaher Corp - Enterprise Value|BDX - Enterprise Value|STE (STERIS plc) - Real Price to Acquire Entire Company|Total Enterprise Value westpharma.com (WST)|Total Company Value Baxter|Real Price to Acquire Entire Company Masimo Corp (MASI)|Enterprise Value STVN|TFX - Total Enterprise Value|Enterprise Value MMSI (Merit Medical Systems)|NVST: Business Value|ICU Medical - Enterprise Value|Company Buyout Price LeMaitre Vascular Inc LMAT|ATRC: Enterprise Value|Real Price to Acquire Entire Company STAAR Surgical Co|NAGE (ChromaDex Corp) - Enterprise Value|Enterprise Value zimvie.com|Total Company Value AngioDynamics (ANGO)|Total Company Value CERS (Cerus Corp.)|Alpha Teknova Inc - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash MGRM|Sharps Tech - Enterprise Value|Company Buyout Price InfuSystem Holdings INFU|Utah Medical Products, Inc. (UTMD) - Total Company Value|Business Value KRMD|Total Company Value Nyxoah, S.A.|Microbot Medical, Inc (MBOT) - Company Buyout Price|Real Price to Acquire Entire Company PDEX (Pro-Dex, Inc.)|Aggregate Business Value ZTEK|Total Company Value Elutia ELUT|Value Adjusted for Debt and Cash MLSS|NXGL: Real Price to Acquire Entire Company|RVP - Enterprise Value|Harvard Bioscience (HBIO) - Total Company Value|Real Price to Acquire Entire Company femasys.com|MHUA (Meihua Medical Technologies) - Enterprise Value|Total Enterprise Value Predictive Oncology Corp POAI|Total Company Value Callan JMB Inc (CJMB)|Atrion Corporation Inc. - Business Value|NeuroMetrix, Inc. - Real Price to Acquire Entire Company